SD7-18876-40427
2 vaccinations
2 coded responses
16 check-ins
2 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 21-25
- ZIP prefix
- 300 / GA
- Registered
- 2021-03-22
- Relationship
- Self
- Race
- White
- Ethnicity
- Hispanic or Latino
Timeline
-
2021-03-22
Registered in v-safe
-
2021-03-23
Dose 1 — Pfizer-BioNTech
- 2021-03-23
-
2021-03-24
Health check-in — days 1–6 daily, dose 1Feeling: Good · Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2021-03-25
- 2021-03-28
- 2021-03-29
- 2021-04-06
-
2021-04-14
Dose 2 — Pfizer-BioNTech
- 2021-04-14
- 2021-04-15
- 2021-04-17
- 2021-04-19
- 2021-04-21
- 2021-04-28
- 2021-05-07
- 2021-05-28
-
2021-10-13
Survey response — 6 months, dose 2MedDRA: Influenza, Malaise, Nasopharyngitis — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitFree text: Cold/flu/covid symptomsMedDRA releases: 2024-11 · check-in free text available
-
2021-10-13
Report sent to call center — 6 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
- 2021-10-15
-
2022-04-14
Survey response — 12 months, dose 2MedDRA: Malaise, SARS-CoV-2 test positive — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Tested positive for COVID on 1/11/2022 with symptomsMedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-23 | Pfizer-BioNTech | |
| 2 | 2021-04-14 | Pfizer-BioNTech |
Call center
1 call center case
1 unsuccessful
Free text
Release 10 — 6 months, dose 2
Symptoms: Cold/flu/covid symptoms
Release 11 — 12 months, dose 2
Symptoms: Tested positive for COVID on 1/11/2022 with symptoms
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Influenza | · | · | ✓ |
| SD | Malaise | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | SARS-CoV-2 test positive | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release